The presence of valve calcification increases the odds of at least mild paravalvular regurgitation after transcatheter aortic valve replacement (TAVR), according to a study published in the August ...

Leaflet calcification and hemodynamic valve deterioration (HVD) of surgically implanted bioprosthetic aortic valves are independently associated with a major increase in death or valve reintervention, ...

Partially calcified valve leaflet tissue, including unaltered collagen (blue), calcified collagen (yellow to red) and aggregated calcium phosphate nodules. CHAMPAIGN, Ill. — The human body has ...

Aortic valve disease encompasses a spectrum of disorders affecting the aortic valve, with calcification being a hallmark of the most severe forms. Calcific aortic valve disease (CAVD) is characterised ...

Please provide your email address to receive an email when new articles are posted on . A new study highlights a high prevalence and large extent of aortic valve calcification in patients with ...

PARIS, France—In a small, feasibility study, a new percutaneous device used to fracture calcium deposits in patients with degenerative calcified aortic stenosis to improve leaflet mobility had a ...

Researchers have analyzed gene expression and protein distribution in human aortic valves obtained from valve replacement surgery. Calcific aortic valve disease (CAVD) -- a disease that leaves the ...

The human body has sophisticated defenses against the deposition of calcium minerals that stiffen heart tissues, researchers at the University of Illinois Urbana-Champaign and collaborators at UCLA ...

Calcific aortic stenosis in the elderly is the number one cause of surgical valve replacement in the US and Europe. The incidence of calcific aortic stenosis is increasing as the general age of the ...

PARIS -- For people undergoing valve-in-valve transcatheter aortic valve replacement (TAVR), a dedicated bioprosthetic leaflet splitting device produced better-than-expected results preventing ...

MiRus announced that it successfully enrolled and treated the first patients in the STAR trial of its Siegel transcatheter ...